CXCR2 and Patent ductus arteriosus: Intriguingly, dual targeting of CXCR2+ neutrophils and CCR2+ macrophages also prevents reciprocal increases in immunosuppressive myeloid cells and facilitates T cell immunosurveillance in mouse models of PDA (60).